Hydroxychloroquine: Looking into the Future
Hydroxychloroquine, an antimalarial agent has also been found to possess antidiabetic action. Onset of type-2 diabetes (T2DM) and cardiovascular disease is now considered to be the outcome of systemic inflammation. Many clinical trials are targeting systemic inflammation to reduce cardiovascular ris...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2017-12-01
|
| Series: | Romanian Journal of Diabetes Nutrition and Metabolic Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/rjdnmd-2017-0043 |